MAP2K7 and sinus histiocytosis with massive lymphadenopathy: Another reported case found that a topical MEK inhibitor, trametinib, was effective in treating cutaneous RDD when combined with oral methotrexate and intralesional triamcinolone injections applied directly to the lesions.7